期刊文献+

脂联素对钙化大鼠血管组织的影响

Influence of adiponectin on vascular calcification in rats
下载PDF
导出
摘要 目的观察脂联素及其受体在钙化大鼠血管组织中的变化,探讨脂联素(adiponectin,APN)对钙化组织的作用。方法大鼠随机分为正常对照组、钙化组和脂联素组。制备大鼠血管钙化模型。用ELISA法测定血浆和血管组织中脂联素的含量,用real-time PCR方法检测组织中脂联素与其受体adipo R1的mRNA水平,用Western blot方法检测组织中受体adipo R1蛋白含量,测定血管中钙含量及碱性磷酸酶活性。结果与对照组相比,钙化大鼠血浆和血管组织中脂联素的含量明显降低,分别降低了47.1%和57.1%;钙化组大鼠血管组织中APN和adipo R1 mRNA水平较对照组有显著降低,分别降低了65.0%和72.0%;钙化大鼠的血管组织中adipo R1蛋白降低了77.2%(均P<0.01)。给予脂联素的大鼠血管组织中钙含量和碱性磷酸酶活性分别降低68.5%和34.8%(P<0.01)。结论钙化的血管组织中APN与其受体adipoR1系统是明显下调,APN可明显抑制钙化大鼠血管组织中钙含量和碱性磷酸酶的活性,提示APN可抑制维生素D3和尼古丁引起的血管钙化。 Objective To observe the changes of adiponectin and its receptors in vascular calcification,and the role of adiponectin on calcified tissues. Methods Male SD rats were induced vascular calcification by vitamin D3 and nicotine,with or without adiponectin. Calcium and alkaline phosphatase( ALP) were assayed. The levels of APN in plasma and vascules were measured by ELISA. The mRNA levels of APN and adipo R1 were detected by using real-time PCR,the level of adipo R1 protein was detected by Western blotting. Results Compared with control group,the APN concentrations in plasma and calcified blood vessels decreased by47. 1% and 57. 1%,respectively. The mRNA levels of APN and adipo R1 decreased by 65. 0% and 72. 0%. The adipo R1 protein decreased by 77. 2%( P〈0. 01). 6. 55 fold increase calcium and 83. 4% increase in ALP activity were observed in calcified blood vessels than that in control group,while APN treatment down-regulated the calcium and ALP activity by 68. 5% and 34. 8%( P〈0. 01).Conclusions In calcified blood vessels,the APN and adipo R1 system are down-regulated,and APN decreases the calcium and ALP activity,suggesting that APN may have cardiovascular protection by antagonizing calcification.
作者 闫亮 王昆
出处 《武警医学》 CAS 2015年第8期808-811,共4页 Medical Journal of the Chinese People's Armed Police Force
关键词 血管钙化 脂联素 脂联素受体 vascular calcification adiponectin adipo R1
  • 相关文献

参考文献11

  • 1Bostrora K. Insights into the mechanism of vascular cal-cification [J], Am J Cardiol, 2001,88 (2) : 20-22.
  • 2刘洪岩,谭洪勇,张金国.脂联素在心血管疾病中的研究进展[J].中国实用医药,2009,4(27):229-232. 被引量:3
  • 3吴胜英,张宝红,蒋宏峰,潘春水,庞永政,唐朝枢,齐永芬.血管钙化对血管组织内皮素表达的影响[J].中国动脉硬化杂志,2003,11(4):277-282. 被引量:13
  • 4Liao Y,Takashima S,Maeda N, et al. Exacerbation ofheart failure in adiponectin-deficient mice due to im-paired regulation of AMPK and glucosemetabolism [ J].Cardiovasc Res,2005 , 67(4) : 705-713.
  • 5Antoniades C,Antonopoulos A S,Tousoulis D,et al.Adiponectin: from obesity to cardiovascular disease[ J].Obes Rev, 2009,10(3) : 269-279.
  • 6张宝红,杜军保,唐朝枢.血管钙化的调节机制[J].心血管病学进展,2003,24(3):179-182. 被引量:6
  • 7Cai X J, Chen L, Li L, et al. Adiponectin inhibits li-popolysaccharide-induced adventitial fibroblast migrationand transition to myofibroblasts via AdipoRl -AMPK-iN-OS pathway [ J ]. Mol Endocrinol, 2010,24 ( 1 ):218-228.
  • 8Tomizawa A,Hattori Y,Kasai K. Induction of gene ex-pression in response to globular adiponectin in vascularendothelial cells [ J ]. Life Sci, 2009, 85 ( 11-12 ):457461.
  • 9Zoico E, Garbin U, Olioso D, et al. The effects of adi-ponectin on interleukin-6 and MCP-1 secretion in lipopo-lysaccharide-treated 3T3-L1 adipocytes : role of the NF-kappaB pathway [ J ] _ Int JMol Med,2009 , 24 ( 6 ):847-851.
  • 10Bostrom K, Watson K E, Horn S, et al. Bone morpho-genetic protein expression in human atherosclerotic le-sions [J]. J Clin Invest, 1993,91(4) : 1800-1809.

二级参考文献77

  • 1郭杰,常志文.冠心病不同病变支数与血清脂联素的相关性[J].临床荟萃,2005,20(11):607-609. 被引量:11
  • 2Takahashi M, Arita Y, Yamagata K, et al, Genomic structure and mutations in adipose-specific gene, adiponectin. Int J Obse Relat Metab Disord, 2000, 24(7) : 851-868.
  • 3Pajvani UB, Hawkins M, Combs TP, et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem, 2004, 279 ( 13 ) : 12152-12162.
  • 4Vasseur F, Helbecque N, Dina C,et al. Single-nueleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Cancasians. Human Molecular Genetics,2002,11(21) :2607-2614.
  • 5Beylot M, Pinteur C, Peroni O. Expression of the adiponectin receptors AdipoR1 and AdipoR2 in lean rats and in obese Zucker rats. Metabolism,2006, 55 (3) : 396-401.
  • 6Liao Y, Takashima S, Maeda N, et al. Exacerbation of heart failure in adiponectin-deficient mice due to impaired regulation of AMPK and glucose metabolism . Cardiovasc Res, 2005,67 (4) : 705-713.
  • 7Ding G, Qin Q, He N, et al. Adiponeetin and its receptors are expressed in adult ventricular cardiomyocytes and upregulated by activation of peroxisome proliferator-activated receptor gamma. J Mol Cell Cardiol,2007, 43 ( 1 ) :73-84.
  • 8Pilz S, Maerz W, Weihrauch G, et al. Adiponectin serum concentrations in men with coronary artery disease: the LUdwigshafen Risk and Cardiovascular Health (LURIC) study. Clin Chim Acta, 2006, 364(1-2) :251-255.
  • 9Ouchi N, Walsh K. A Novel Role for Adiponectin in the Regulation of Inflammation. Arteriosclerosis, Thrombosis, and Vascular Biology,2008,28(7) : 1219-1221.
  • 10Do D, Alvarez J, Chiquette E, et al. The good fat hormone : adiponectin and cardiovascular disease. Curr Atheroscler Rep, 2006,8 (2) : 94 -99.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部